GI Innovation allergic diseases treatment

Carbon neutrality SK Innovation E&S, JB Financial team up for renewable energy loans

JB Financial Group Co., the parent company of Jeonbuk Bank and Gwangju Bank, will join hands with SK Innovation E&S Co. and InnerGen Co. to roll...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Korean Investors Samsung to invest $10 million in US-based C2N Diagnostics

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

Energy Trump-driven energy boom spurs Korean firms to hike US gas investments

WOODFORD, Oklahoma – A shale gas field in Woodford, Carter County was bustling with activity on Feb. 25.A team of engineers oversaw the drilli...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Energy SK Innovation E&S to secure 10 mn tons of LNG to compete with BP, Shell

SK Innovation E&S (SKI E&S), the natural gas business unit of South Korea’s SK Innovation Co., is set to begin an LNG trading business...

Corporate restructuring SK Ecoplant seeks to sell waste treatment business for $1.4 billion

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...

Mergers & Acquisitions LG Chem embarks on sale of dermal filler business worth $343 million

LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Bio & Pharma Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Bio & Pharma SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

Banking & Finance Hanwha's financial companies open AI center in San Franciso

South Korea’s seventh-largest conglomerate’s financial companies have opened a joint artificial intelligence center in San Francisco, a ...

Bio & Pharma Celltrion gets approval of Omlyclo in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

Retail GS Retail selects six startups to innovate retail biz

South Korea's GS Retail said on Friday it selected six startups—Studio Lab, Tilda, Oasis Business, YesPlzAI, Vessl AI, and Raondata—th...

Bio & Pharma Celltrion releases Steqeyma in Europe

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

Corporate bonds S&P upgrades SK Innovation credit rating to BBB-

Global credit rating agency Standard & Poor's (S&P) announced on Friday that it upgraded SK Innovation Co.'s long-term credit rating from a ...

Corporate restructuring SK Innovation-SK E&S merger creates Asia’s No. 1 energy supplier

SK Group on Friday launched the merged entity between SK Innovation Co. and liquefied natural gas supplier SK E&S Co., a key step in the energy-...

Bio & Pharma Celltrion's Zymfentra gets 90% distribution channel in US

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

Energy DS Dansuk wins $750 mn SAF material order from Phillips 66

South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...

Chemical Industry LG Chem opens Europe Innovation Center in Germany

South Korea's LG Chem Ltd., the world’s fourth-largest chemicals manufacturer, said on Sunday the opening of its Europe Innovation Center in F...

Bio & Pharma ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment

ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...

Bio & Pharma Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Korean startups Hyundai Motor Group, D.Camp to host startup demo day

Hyundai Motor Group's open innovation platform ZER01NE said on Tuesday it partnered with startup accelerator D.Camp in collaboration with 19 finan...

Electric vehicles Hyundai, Kia’s H1 vehicle sales in Singapore double

South Korea’s top automaker Hyundai Motor Group said on Sunday its vehicle sales in Singapore, a high-tech innovation hub, more than doubled i...

Electronics LG NOVA hosts Innovation Festival in US

LG Electronics Inc. 's North American Innovation Center (LG NOVA) said on Monday that it held an Innovation Festival last Wednesday and Thursday at ...

Artificial intelligence Microsoft, KT join forces to propel Korea’s AI innovation

Microsoft Corp. and KT Corp., one of South Korea's top three telecom companies, will drive artificial intelligence transformation in the Korean firm...

Bio & Pharma Osstem Implant to boost digital dentistry business

South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...

Artificial intelligence 42Maru builds defense-specialized GenAI platform

42Maru, South Korea's generative AI and language AI startup said on Friday that it was selected as the lead organization for the Defense Technolog...

Korean stock market Mirae Asset named as Best Securities House in S.Korea by Euromoney

Mirae Asset Securities announced on Thursday that it has been named “Best Securities House in South Korea” at the Euromoney Securities H...